BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29241727)

  • 1. Simple classifiers for molecular subtypes of colorectal cancer.
    Kim WG; Kim JY; Park DY
    Arab J Gastroenterol; 2017 Dec; 18(4):191-200. PubMed ID: 29241727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early-stage serrated adenocarcinomas are divided into several molecularly distinct subtypes.
    Hirano D; Urabe Y; Tanaka S; Nakamura K; Ninomiya Y; Yuge R; Hayashi R; Oka S; Kitadai Y; Shimamoto F; Arihiro K; Chayama K
    PLoS One; 2019; 14(2):e0211477. PubMed ID: 30785889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of Colorectal Cancer in Molecular Subtypes by Immunohistochemistry.
    Ten Hoorn S; Trinh A; de Jong J; Koens L; Vermeulen L
    Methods Mol Biol; 2018; 1765():179-191. PubMed ID: 29589308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.
    Li X; Larsson P; Ljuslinder I; Ling A; Löfgren-Burström A; Zingmark C; Edin S; Palmqvist R
    Pathol Res Pract; 2021 Apr; 220():153379. PubMed ID: 33721619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry.
    Trinh A; Trumpi K; De Sousa E Melo F; Wang X; de Jong JH; Fessler E; Kuppen PJ; Reimers MS; Swets M; Koopman M; Nagtegaal ID; Jansen M; Hooijer GK; Offerhaus GJ; Kranenburg O; Punt CJ; Medema JP; Markowetz F; Vermeulen L
    Clin Cancer Res; 2017 Jan; 23(2):387-398. PubMed ID: 27459899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of CDX2/CK20 expression is associated with poorly differentiated carcinoma, the CpG island methylator phenotype, and adverse prognosis in microsatellite-unstable colorectal cancer.
    Kim JH; Rhee YY; Bae JM; Cho NY; Kang GH
    Am J Surg Pathol; 2013 Oct; 37(10):1532-41. PubMed ID: 24025523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BRAF-mutated microsatellite stable colorectal carcinoma: an aggressive adenocarcinoma with reduced CDX2 and increased cytokeratin 7 immunohistochemical expression.
    Landau MS; Kuan SF; Chiosea S; Pai RK
    Hum Pathol; 2014 Aug; 45(8):1704-12. PubMed ID: 24908142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.
    Seppälä TT; Böhm JP; Friman M; Lahtinen L; Väyrynen VM; Liipo TK; Ristimäki AP; Kairaluoma MV; Kellokumpu IH; Kuopio TH; Mecklin JP
    Br J Cancer; 2015 Jun; 112(12):1966-75. PubMed ID: 25973534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of CpG island methylator phenotype (CIMP)-high, -low, and -negative colorectal cancers based on protein marker expression and molecular features.
    Zlobec I; Bihl M; Foerster A; Rufle A; Lugli A
    J Pathol; 2011 Nov; 225(3):336-43. PubMed ID: 21660972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of microsatellite instability on recurrence patterns and outcomes in colorectal cancers.
    Kim CG; Ahn JB; Jung M; Beom SH; Kim C; Kim JH; Heo SJ; Park HS; Kim JH; Kim NK; Min BS; Kim H; Koom WS; Shin SJ
    Br J Cancer; 2016 Jun; 115(1):25-33. PubMed ID: 27228287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between genetic alterations and prognosis in sporadic colorectal cancer.
    Chang SC; Lin JK; Yang SH; Wang HS; Li AF; Chi CW
    Int J Cancer; 2006 Apr; 118(7):1721-7. PubMed ID: 16231316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemistry-Based Consensus Molecular Subtypes as a Prognostic and Predictive Biomarker for Adjuvant Chemotherapy in Patients with Stage II Colorectal Cancer.
    Li Y; Yao Q; Zhang L; Mo S; Cai S; Huang D; Peng J
    Oncologist; 2020 Dec; 25(12):e1968-e1979. PubMed ID: 32926498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
    Schiemann U; Müller-Koch Y; Gross M; Daum J; Lohse P; Baretton G; Muders M; Mussack T; Kopp R; Holinski-Feder E
    Digestion; 2004; 69(3):166-76. PubMed ID: 15118395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma.
    Wright CM; Dent OF; Newland RC; Barker M; Chapuis PH; Bokey EL; Young JP; Leggett BA; Jass JR; Macdonald GA
    Gut; 2005 Jan; 54(1):103-8. PubMed ID: 15591513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of CDX2 in colorectal cancer is associated with histopathologic subtypes and microsatellite instability but is prognostically inferior to hematoxylin-eosin-based morphologic parameters from the WHO classification.
    Konukiewitz B; Schmitt M; Silva M; Pohl J; Lang C; Steiger K; Halfter K; Engel J; Schlitter AM; Boxberg M; Pfarr N; Wilhelm D; Foersch S; Tschurtschenthaler M; Weichert W; Jesinghaus M
    Br J Cancer; 2021 Dec; 125(12):1632-1646. PubMed ID: 34616012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite instability & survival in patients with stage II/III colorectal carcinoma.
    Srdjan M; Jadranka A; Ivan D; Branimir Z; Daniela B; Petar S; Velimir M; Zoran K
    Indian J Med Res; 2016 May; 143(Supplement):S104-S111. PubMed ID: 27748284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic Pattern of Stage IV Colorectal Cancer with High-Frequency Microsatellite Instability as a Prognostic Factor.
    Fujiyoshi K; Yamamoto G; Takenoya T; Takahashi A; Arai Y; Yamada M; Kakuta M; Yamaguchi K; Akagi Y; Nishimura Y; Sakamoto H; Akagi K
    Anticancer Res; 2017 Jan; 37(1):239-247. PubMed ID: 28011498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-Level Microsatellite Instability as a Potential Prognostic Factor in Sporadic Colorectal Cancer.
    Lee SY; Kim DW; Lee HS; Ihn MH; Oh HK; Min BS; Kim WR; Huh JW; Yun JA; Lee KY; Kim NK; Lee WY; Kim HC; Kang SB
    Medicine (Baltimore); 2015 Dec; 94(50):e2260. PubMed ID: 26683947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and epigenetic classifications define clinical phenotypes and determine patient outcomes in colorectal cancer.
    Sanchez JA; Krumroy L; Plummer S; Aung P; Merkulova A; Skacel M; DeJulius KL; Manilich E; Church JM; Casey G; Kalady MF
    Br J Surg; 2009 Oct; 96(10):1196-204. PubMed ID: 19787768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sporadic colorectal carcinomas with low-level microsatellite instability in Korea: do they form a distinct subgroup with distinguished clinicopathological features?
    Kim YH; Min BH; Choi HK; Kim SJ; Kim KM; Kim JY; Chang DK; Son HJ; Rhee PL; Kim JJ; Rhee JC; Chun HK
    J Surg Oncol; 2009 May; 99(6):351-5. PubMed ID: 19204939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.